Related Experiment Video
Updated: Dec 25, 2025
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.4K
Pulmonary Function Changes in Chronic Obstructive Pulmonary Disease Patients According to Smoking Status
1Interdisciplinary Allergy Outpatient Clinic, Department of Pneumology, University of Lübeck, Germany.
Turkish Thoracic Journal
|March 24, 2020
Summary
Continuing to smoke accelerates pulmonary function decline in chronic obstructive pulmonary disease (COPD) patients. Smoking cessation is crucial, especially for early-stage COPD patients, to improve lung function and prevent disease progression.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Research
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease.
- Smoking is a primary risk factor for COPD development and progression.
- Understanding the impact of smoking status on pulmonary function across all COPD stages is essential for effective management.
Purpose of the Study:
- To investigate the effect of smoking status on pulmonary function in patients with all stages of COPD.
- To compare lung function changes between COPD patients who continued smoking and those who quit.
- To identify optimal strategies for smoking cessation in COPD management.
Main Methods:
- A retrospective case-control study involving 148 COPD patients.
- Patients were categorized into two groups: smokers (n=80) and quitters (n=68).
- Pulmonary function parameters, COPD assessment test scores, and smoking history were analyzed over a 12-month period.
Main Results:
- COPD patients who continued smoking experienced accelerated decline in FEV1 (Forced Expiratory Volume in 1 second).
- COPD patients who quit smoking showed an increase in FEV1, with improvements observed across various stages.
- Early-stage (Stage-0) COPD smokers exhibited the most significant FEV1 reduction, highlighting the critical need for intervention.
Conclusions:
- Smoking cessation significantly improves pulmonary function in COPD patients.
- Inhaler treatments alone did not prevent FEV1 decline in continuing smokers.
- The current Global Initiative for Chronic Obstructive Lung Disease guidelines should be revised to include Stage-0 patients in smoking cessation strategies.
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.4K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.0K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.0K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.0K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.0K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.4K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.4K